Bolt Biotherapeutics Inc

XNAS:BOLT 3:02:29 PM EDT

3.85

+0.11 (+2.94%)

4:30:08 PM EDT: $3.89 +0.04 (+1.04%)

Market Cap (Intraday)	7.42M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.43 Million
Adjusted EPS	-$3.52

See more estimates

10-Day MA	$3.63
50-Day MA	$3.91
200-Day MA	$4.77

See more pivots

Bolt Biotherapeutics Inc Stock, XNAS:BOLT

900 Chesapeake Drive, Redwood City, California 94063

United States of America

Phone: +1.650.665.9295

Number of Employees: 100

http://www.boltbio.com

Description

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.